A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7497372 in Participants With Diabetic Macular Edema (DME)
Clinical trial NCT06847854 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06847854
- Sponsor
- Genentech, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-08
- Primary completion
- 2026-11-16
- Enrollment
- 151
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.